Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Asset Utilization Ratio (2016 - 2025)

CytomX Therapeutics' Asset Utilization Ratio history spans 11 years, with the latest figure at 0.49 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 53.78% year-over-year to 0.49; the TTM value through Dec 2025 reached 0.49, down 53.78%, while the annual FY2025 figure was 0.56, 34.64% down from the prior year.
  • Asset Utilization Ratio reached 0.49 in Q4 2025 per CTMX's latest filing, down from 0.68 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.35 in Q1 2025 to a low of 0.07 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.47, with a median of 0.4 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: soared 142.48% in 2023, then crashed 53.78% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.11 in 2021, then soared by 107.75% to 0.22 in 2022, then soared by 119.38% to 0.48 in 2023, then skyrocketed by 122.38% to 1.06 in 2024, then plummeted by 53.78% to 0.49 in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Asset Utilization Ratio are 0.49 (Q4 2025), 0.68 (Q3 2025), and 1.03 (Q2 2025).